Wockhardt: is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals.

Wockhardt is a true Indian Multi-National Company with a multi-ethnic workforce of 8600 Wockhardt Associates from 21 different nationalities globally. It has 3 research centres and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines.

Wockhardt Rights Issue Date, Details, Price

Issue Start Date:	15 March 2022
Issue Close Date:	22 March 2022
Issue Size	747.90 Crores
Price	225 Per share
Ratio	Issue of 03 equity shares of 10 equity shares held.
Face value	5 per share
Market lot	1 per share
Listing At	BSE, NSE
Equity	3.32 Crore
Letter	Download

Wockhardt Rights Issue Timetable

Record Date:	09 March 2022
Deemed Date of Allotment:	30 March 2022
Renunciation of Rights Entitlements:	16 March 2022

Wockhardt Rights Issue Contact Details

Wockhardt Ltd
Wockhardt Towers, Bandra-Kurla Complex
Bandra East, Mumbai 400 051
Phone: +91 22 2659 6228
Email: [email protected]
Website: http://www.wockhardt.com/

Wockhardt Rights Issue Registrar

Link Intime India Private Ltd
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai – 400083
Website: https://linkintime.co.in/
Email: [email protected]
Phone: +91-22-4918 6270
Fax: +91-22-4918 6060

Wockhardt Rights Issue Lead Managers

Ambit Private Limited